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Abstract
The rate of labor induction is steadily increasing and, in industrialized
countries, approximately one out of four pregnant women has their labor
induced. Induction of labor should be considered when the benefits of
prompt vaginal delivery outweigh the maternal and/or fetal risks of waiting
for the spontaneous onset of labor. However, this procedure is not free of
risks, which include an increase in operative vaginal or caesarean delivery
and excessive uterine activity with risk of fetal heart rate abnormalities. A
search for “Induction of Labor” retrieves more than 18,000 citations from
1844 to the present day. The aim of this review is to summarize the
controversies concerning the indications, the methods, and the tools for
evaluating the success of the procedure, with an emphasis on the scientific
evidence behind each.
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Introduction
Induction of labor (IOL) is certainly one of the most frequently 
performed obstetric procedures in the world: recent data indicate 
a percentage of induction of up to 35.5% in Sri Lanka1, 24.5% 
in the United States2, and from 6.8 to 33% in Europe3. In spite of 
the extreme diffusion of the procedure, there are still numerous 
unanswered questions, or questions that have not obtained a 
unanimous consensus in the scientific literature. In general, it is 
universally accepted that IOL is indicated when it is thought that 
the outcomes for the fetus, the mother, or both are better than with 
expectant management, that is waiting for the spontaneous onset 
of labor4–7; in addition, IOL should be taken into consideration 
when the vaginal route is thought to be the most appropriate for 
delivery, a concept that is broader than the simple absence of 
contraindications to vaginal birth. Furthermore, being a medical 
procedure, IOL should be carried out only when there is informed 
consent4,5,8 and where the precursor for the induction, including 
specific risks and benefits and the choice of the method used, are 
clearly explained; furthermore, I personally believe that consent 
should be accompanied by data on the success of the procedure 
in the birth center. A general concern is that IOL might increase 
the rate of cesarean delivery and have an impact on the experience 
of birth, as in women undergoing IOL it is generally less favora-
ble, even though it is not always easy to separate the effect of the 
procedure per se from that of the perception of the obstetric risk 
that makes IOL necessary or from its outcome. In other words, 
the mother can perceive childbirth complicated by a risk that 
makes IOL necessary or that ends with a caesarean section as 
negative or less positive. When it comes to IOL, the factors to 
be taken into consideration and that can influence its success are 
many: among them, the precursor to induction, i.e. the clinical 
condition, present or absent, at the time the decision to induce is 
taken, the woman’s characteristics, the method of induction used, 
and other factors that can predict the success of the induction. 
However, it should be borne in mind that the current literature is 
not unanimous in defining certain key points such as the definition 
for failed induction or even what to consider as the success of the 
induction. We will address these points individually.
Precursors for induction
Table 1 presents a summary of the five guidelines available on 
the subject4–8. The first line presents a general summary of the 
precursors with some guidelines being specific of some clinical 
situations while others remain more generic. In the case of the 
American College of Obstetricians and Gynecologists (ACOG), 
for instance, this vagueness is compensated for by the presence of 
a series of publications referring to specific clinical situations9–13, 
in which the possibility of induction is dealt with. Given the gen-
erality of the concept that IOL is indicated when terminating 
pregnancy is better than expectant management, I have then 
chosen to insert a series of specific precursors, those reported by 
the National Institute for Health and Care Excellence (NICE), the 
oldest of the guidelines, and then verify possible changes over 
time in the more recent.
For some precursors, there is a general consensus that recommends 
induction: for example, for pregnancy at or beyond term where 
everyone agrees on the induction between 410 and 417 weeks4–9,14 
or for pre-labor rupture of the membranes (PROM)4–8,11,15. For 
others, there is a general consensus that instead does not 
recommend induction: in the case of fetal macrosomia, all 
guidelines agree that macrosomia, by itself, should not be 
considered a precursor for induction (Table 110). However, a recent 
study that randomized 818 women, including approximately 10% 
diabetic patients in each group, with singleton fetuses whose 
estimated weight exceeded the 95th percentile showed that IOL 
for suspected macrosomia is associated with a reduced risk of 
shoulder dystocia and associated morbidity compared with 
expectant management, with no increase in cesarean delivery 
rate16. The results of this study have changed the conclusions of 
the Cochrane review on this topic17,18.
A particular mention should be made of the so-called elective 
induction: the Society of Obstetricians and Gynaecologists of 
Canada (SOGC)8 defines it as IOL in the absence of acceptable 
fetal or maternal indications. NICE4 more generally defines 
“elective” clinical procedures that are planned rather than becom-
ing necessary as emergencies and therefore applicable to other 
procedures as well (the most frequent being caesarean delivery). 
In the Queensland guidelines5, elective induction seems to coin-
cide with induction by maternal request. In truth, the concept of 
elective induction has increasingly been defined as an induction 
at term, without an apparent clinical reason, in order to improve 
maternal and perinatal outcomes. To my knowledge, the first 
reference dates back to 194719, and since then many 
observational studies20–28 and some randomized studies (revised 
in29,30) have been published. The latest contribution is that of the 
Maternal–Fetal Medicine Units Network which, in August 201831, 
published the results of a multicenter trial that included 6,106 
low-risk women randomized to receive IOL at 390–394 weeks or 
expectant management. The primary outcome of the study was a 
composite of perinatal death or severe neonatal complications and 
the conclusions were that elective induction does not reduce the 
composite adverse perinatal outcome but nevertheless results in a 
significantly lower frequency of cesarean delivery (18.6% versus 
22.2%; relative risk 0.84; 95% confidence interval [CI] 0.76 to 
0.93) However, a most recent systematic review and meta-analysis 
of 7 randomized controlled trials with 7598, has shown no effect on 
the cesarean delivery rates32. The rationale for elective inductions 
would be to manage pregnancies between 390 and ≤410 weeks, as 
before and after these gestational ages perinatal outcomes are worse 
than at term9,33. Overall, the results of these studies do not show 
clear evidence that a policy of elective induction in low-risk parturi-
ents brings a clear advantage29,30. In addition, it has been pointed out 
that IOL requires a range of human resources, services, monitoring, 
and interventions, all of which should be available if elective IOL is 
to be conducted safely34.
Another specific mention should be made of IOL after a previ-
ous cesarean delivery: the conclusions of a recent review and 
meta-analysis on eight retrospective studies published between 
2000 and 201335 are that IOL slightly increases the risk of uterine 
rupture/dehiscence (1.1% versus 0.6%; OR 1.62; 95% CI 
1.13–2.31) and of repeat cesarean delivery. However, IOL might 
be necessary in women with a previous cesarean delivery and 
should be considered a reasonable option provided that all possible 
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measures are put in place to safeguard the well-being of mother 
and child12.
In conclusion, for very few of the precursors reported in the 
guidelines (Table 1) and in the scientific literature36–41, there is 
clear evidence that IOL actually improves the obstetric and/or 
perinatal outcome. An example for all is isolated oligohydram-
nios at term, a popular precursor for IOL: a recent meta-analysis42 
including 2,414 women with oligohydramnios and 33,585 
controls but only one randomized trial with about 50 women 
showed that oligohydramnios represents a risk factor for IOL, 
caesarean section, and short-term neonatal morbidity. However, 
it is difficult to define precisely whether the outcomes represent 
the effect of IOL itself or that of the precursor. The same 
applies to other clinical situations in the presence of maternal 
and/or fetal pathology.
Success and failure of induction of labor
These two terms would seem contradictory: if IOL succeeds, it 
certainly has not failed. However, even from this point of view, 
there is no complete uniformity in the literature. In fact, for 
induction success, some mean obtaining a vaginal birth, others 
add “not complicated”, “within 24 hours from the beginning of the 
induction”, or “reaching the active phase of labor” (see also 
Table 1). The main problem lies in the fact that success and 
failure in this case are not opposed: in general, the success of 
IOL should be represented by the achievement of a vaginal 
birth, even if it is operative, without a defined time limit (in other 
words, if the birth happens within 49 hours of the induction, does 
it represent an unsuccessful IOL?). This is particularly true in the 
case of obese women, for example, in whom it has been reported 
that IOL may take longer than in women of normal weight43. 
A different issue is the failure of induction, that is the failure of 
the process that should have led to labor, independently from its 
outcome: in this sense, failure should be only one of the possible 
reasons why a vaginal birth is not obtained, should be related 
to the procedure per se, and should not be confused with the arrest 
of labor in the first or second stage once the active phase has 
started. However, if we look at Table 1, the uniformity between 
the guidelines is completely lacking: even in the case of NICE4, 
it seems that induction failure coincides with the non-achievement 
of cervical ripening. It is evident that an agreement of what 
induction failure represents is crucial because it heavily affects 
the cesarean delivery rate, and many definitions have been 
reported44,45. In the ACOG/Society for Maternal–Fetal Medicine 
(SMFM) consensus on the safe prevention of the primary cesarean 
delivery46, it is stated that “if the maternal and fetal status allow, 
cesarean deliveries for the induction of labor in the latent phase 
can be avoided by allowing longer durations of the latent phase 
(up to 24 hours or longer) and requiring that oxytocin be 
administered for at least 12–18 hours after membrane rupture 
before deeming the induction a failure”. Furthermore, in order to 
deny the definition of arrest of labor in the first stage, it is neces-
sary to have reached at least 6 cm of dilation. This definition of 
failure is confirmed by the American Maternal–Fetal Medicine Units 
Network in a recent study of more than 10,000 women47. In 
conclusion, it seems reasonable to say that an induction did not 
fail without oxytocin being administered to induce contractions.
Prediction of successful labor induction
The identification of the factors associated with the success of the 
induction, intended as vaginal delivery, is fundamental for a pro-
cedure which is considered to contribute to the increase in the 
cesarean delivery rate48–50. One of the main factors is certainly 
the assessment of the cervix. From the time of its presentation51, 
the Bishop score (BS) is the most used method to assess the 
cervix52 (Table 1), with a BS of 6 or less indicating an unfavorable 
cervix and a score of 8 or more a favorable one (and a BS of 7 
being homeless). A review that considered more than 40 relatively 
mediocre-quality articles that correlated the BS at the beginning 
of the induction with its outcome concluded that BS is a poor 
predictor and should not be used to decide whether or not to induce 
labor53. In an attempt to increase its predictive value, a series of 
clinical and biochemical parameters have been added54,55. A modi-
fied simplified BS has also been proposed which includes only 
dilation, station, and effacement56,57 alone or in combination 
with other parameters58. The predictive capacity of the trans-
vaginal sonographic assessment of the cervix has also been 
evaluated59–61 either by itself or in combination with other 
parameters58,62–66. At present, however, the BS remains the main 
tool for the assessment of the cervix at the beginning of the 
induction and for the evaluation of cervical ripeness (i.e. its 
changes) during the induction process.
Other factors that have been associated with the success of the 
induction are parity67, gestational age and size of the fetus68, body 
mass index (BMI)43,69, age of the mother and the presence of 
comorbidities70, and biochemical markers such as fibronectin, 
activin A, and insulin growth factor binding protein-148,49,71,72 
either alone or variously combined54,55,63,71,72. There is a general 
agreement in considering parity as a major predictor of IOL 
success73–75. Regarding the gestational age, IOL success of late 
preterm (34–366 weeks) is similar to that of term pregnancies68, 
while in weeks between 24 and 336 it varies between 56.9 and 
66.7%, considering only live births. In principle, it can be said 
that the success of the induction, meaning vaginal birth, increases 
with the gestational age and that >50% of women (also nulliparous 
with an unripe cervix) give birth vaginally76. Scoring systems73, 
nomograms74, and prediction model systems75 have been proposed 
but have not been validated yet77. Recently, a systematic review 
of 14 models derived or validated since 1966 has provided a list 
of recommendations for improving the performance and utilization 
of the models78.
Methods of induction
The literature concerning the various methods of labor induction 
(i.e. cervical ripening and the onset of uterine contractions) 
discusses the effectiveness of pharmacological, mechanical, 
investigational, and complementary and alternative medicine 
means of third trimester IOL79–84. The pharmacological meth-
ods are oxytocin and prostaglandins (PGE1: misoprostol and 
PGE2: dinoprostone), the latter available in different forms 
(tablet, gel, or insert) and, for misoprostol, with different routes 
of administration (oral titrated solution, buccal/sublingual, 
oral, or vaginal)84,85. Slow-release formulations are also avail-
able for PGEs. In general, PGEs are the drug of choice when 
cervical ripening is needed in the presence of an unfavorable 
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cervix (see Table 1). Cervical ripening can be performed in either 
an outpatient or an inpatient setting86–88. Oxytocin, instead, is used 
when the cervix is favorable (BS 7–8) and is the drug that induces 
contractions. Generally speaking, it could be correct to state that 
an IOL, in the presence of maternal and fetal well-being, 
should not be defined failed before oxytocin administration. 
In other words, NICE’s definition4 of failure of the induction 
appears, according to modern knowledge, difficult to share. Suf-
fice it to say that IOL was widespread practice even before 
the introduction of PGEs and that at the time it was based 
only on the administration of oxytocin, with good results19. 
Among the mechanical methods, the most popular is the Foley 
catheter89,90, either alone91 or in association with oxytocin92–96, or 
misoprostol97,98, and with different balloon volumes99,100. The 
combination of mechanical and pharmacological methods used 
simultaneously does not show clear benefits in terms of mode of 
delivery: the use of the Foley catheter with oxytocin increases the 
rate of delivery within 24 hours in nulliparas95,96, while the asso-
ciation of Foley and misoprostol101 reduces the intervention to 
delivery time interval and the number of uterine hyperstimulations, 
in both cases without influencing cesarean delivery rates.
Alternative methods include castor oil, which has received 
renewed interest in recent times102–104, acupuncture105, breast/ 
nipple stimulation106–108, sexual intercourse109, homeopathy110, and 
hypnotic relaxation111. For all these methods, the role in IOL is 
uncertain, basically because of the lack of studies, if not anecdo-
tal reports. Membrane sweeping deserves a special mention: in 
spite of modest discomfort for the mother, it reduces the number of 
pregnancies beyond term and the need for induction, without 
increasing the infectious risks112. All the cited guidelines rec-
ommend its execution in all women starting from 400 weeks 
to reduce the incidence of IOL and also before the pharmaco-
logical IOL4–8. If the cervix is closed and membrane sweep-
ing is not possible, cervical massage in vaginal fornices 
may achieve similar effect5.
I do not feel able to state favor for one method of cervi-
cal ripening over another: often the choice of the drug to be 
used also passes through local policies, but this is beyond the 
scope of this review. However, consensus seems to be unani-
mous that fetal heart rate should be recorded both before and 
after cervical ripening, intracervical prostaglandins can be 
abandoned, and misoprostol should be avoided in the induction 
of women with a previous cesarean delivery.
Conclusions
The purpose of this review is to give some “food for thought”, 
showing that the variables involved in the process are many and 
ideally should be evaluated on a case-by-case basis. The attempts 
made to create successful prediction systems implemented 
so far are still far from achieving the intended. In conclusion, 
some suggestions can be provided: it would be recommended 
that every birth center should be provided with local guide-
lines regarding the IOL; once started, IOL should be continued 
until the end; there is no evidence that repeated cycles of cervi-
cal ripening are advantageous in terms of successful induc-
tion (and unfortunately the birth experience in women whose 
pre-induction process was eternal has not yet been investi-
gated thoroughly); and the lack of changes of the BS at the end 
of cervical ripening is not synonymous with IOL failure. It has 
been reported that even in nulliparous women with an unfavo-
rable BS, unchanged after the ripening process with PGEs, the 
administration of oxytocin leads to 80% of vaginal deliveries66.
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